The Governors of the University of Calgary
🇨🇦Canada
- Country
- 🇨🇦Canada
- Ownership
- Private
- Established
- 1966-04-29
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.ucalgary.ca
Biomechanical Effects of Wearing a Sacroiliac Belt in Women
Not Applicable
Completed
- Conditions
- Pelvic Girdle Pain
- Interventions
- Device: sacroiliac belt
- First Posted Date
- 2017-11-07
- Last Posted Date
- 2017-11-07
- Lead Sponsor
- University of Calgary
- Target Recruit Count
- 10
- Registration Number
- NCT03334799
Identifying Methods for Postpartum Reduction of Vascular Events: Pilot Randomized Controlled Trial
Not Applicable
- Conditions
- Pre-Eclampsia
- Interventions
- Behavioral: CardioPrevent® Program
- First Posted Date
- 2017-10-05
- Last Posted Date
- 2019-04-18
- Lead Sponsor
- University of Calgary
- Target Recruit Count
- 84
- Registration Number
- NCT03302260
High-Dose Vitamin D Induction in Optic Neuritis
Phase 2
Terminated
- Conditions
- Optic Neuritis
- Interventions
- Drug: Placebo/Standard of Care Vitamin D3
- First Posted Date
- 2017-10-05
- Last Posted Date
- 2024-07-24
- Lead Sponsor
- University of Calgary
- Target Recruit Count
- 12
- Registration Number
- NCT03302585
- Locations
- 🇨🇦
Foothills Medical Centre, University of Calgary, Calgary, Alberta, Canada
Sleeping for Two: RCT of CBT-Insomnia in Pregnancy
Not Applicable
Completed
- Conditions
- Sleep DisturbanceInsomnia
- Interventions
- Other: Cognitive-Behavioural Therapy for Insomnia (CBT-I)
- First Posted Date
- 2017-10-04
- Last Posted Date
- 2018-09-14
- Lead Sponsor
- University of Calgary
- Target Recruit Count
- 54
- Registration Number
- NCT03301727
- Locations
- 🇨🇦
University of Calgary, Calgary, Alberta, Canada
🇨🇦University of Manitoba, Winnipeg, Manitoba, Canada
Intranasal Treatment of HIV-associated Neurocognitive Disorders
Phase 2
Terminated
- Conditions
- HIV Associated Neurocognitive Disorder (HAND)
- Interventions
- Biological: Sterile Saline placeboBiological: IN insulin
- First Posted Date
- 2017-09-08
- Last Posted Date
- 2020-06-11
- Lead Sponsor
- University of Calgary
- Target Recruit Count
- 4
- Registration Number
- NCT03277222
- Locations
- 🇨🇦
Southern Alberta Clinic, Calgary, Alberta, Canada
Shiga Toxin Producing Escherichia Coli (STEC) Volume Expansion
Phase 1
Withdrawn
- Conditions
- Hemolytic-Uremic Syndrome
- Interventions
- Drug: D5-0.9%NSDrug: Routine home oral rehydration
- First Posted Date
- 2017-09-08
- Last Posted Date
- 2020-11-09
- Lead Sponsor
- University of Calgary
- Registration Number
- NCT03275792
- Locations
- 🇨🇦
Alberta Children's Hospital, Calgary, Alberta, Canada
A Clinical Trial of Pimozide in Patients With Amyotrophic Lateral Sclerosis (ALS)
Phase 2
- Conditions
- ALSAmyotrophic Lateral Sclerosis
- Interventions
- Drug: Placebo Oral Tablet
- First Posted Date
- 2017-09-05
- Last Posted Date
- 2020-05-28
- Lead Sponsor
- University of Calgary
- Target Recruit Count
- 100
- Registration Number
- NCT03272503
- Locations
- 🇨🇦
Dr. Lawrence Korngut -South Health Campus, Calgary, Alberta, Canada
🇨🇦Dr. Colleen O'Connell - Stan Cassidy Centre for Rehabilitation, Fredericton, New Brunswick, Canada
🇨🇦Dr. Genevieve Matte, Montréal, Quebec, Canada
Probiotics Supplementation and Intestinal Microbiome in Neonates With Gastrointestinal Surgery
Not Applicable
Terminated
- Conditions
- Infant, NewbornSurgical Procedures, OperativeProbioticsGastro-Intestinal Disorder
- Interventions
- Biological: FloraBabyOther: Placebo
- First Posted Date
- 2017-08-30
- Last Posted Date
- 2024-07-18
- Lead Sponsor
- University of Calgary
- Target Recruit Count
- 2
- Registration Number
- NCT03266315
- Locations
- 🇨🇦
University of Calgary, Calgary, Alberta, Canada
Cerebral Blood Flow and Ventilatory Responses During Sleep in Normoxia and Intermittent Hypoxia
Phase 1
Not yet recruiting
- Conditions
- Blood PressureHypoxia, BrainSleep DisorderStrokeEndothelial DysfunctionObstructive Sleep Apnea of AdultSleep ApneaOxidative Stress
- Interventions
- Drug: Drug Lowering Cerebral Blood Flow (CBF) and Normoxia SleepDrug: Placebo and Normoxia SleepDrug: Placebo and Intermittent Hypoxia SleepDrug: Drug Lowering CBF and Intermittent Hypoxia Sleep
- First Posted Date
- 2017-08-21
- Last Posted Date
- 2022-11-04
- Lead Sponsor
- University of Calgary
- Target Recruit Count
- 12
- Registration Number
- NCT03255408
Treatment of Dysphagia and Ineffective Esophageal Motility With Prucalopride: A Pilot Study
- First Posted Date
- 2017-08-09
- Last Posted Date
- 2020-03-25
- Lead Sponsor
- University of Calgary
- Target Recruit Count
- 28
- Registration Number
- NCT03244553
- Locations
- 🇨🇦
University of Calgary, Calgary, Alberta, Canada
© Copyright 2025. All Rights Reserved by MedPath